STOCKWATCH
·
Pharmaceuticals
USFDA9 Dec 2025, 02:02 pm

Caplin Point's Subsidiary, Caplin Steriles, Receives USFDA Approval for Linezolid Injection

AI Summary

Caplin Point Laboratories Ltd announced that its subsidiary, Caplin Steriles Limited, has received final approval from the USFDA for its ANDA Linezolid Injection 600 mg/ 300 mL (2 mg/mL) Single Dose Infusion Bags. This generic therapeutic equivalent version of the RLD ZYVOX from Pfizer Inc. is primarily used to treat serious bacterial infections. Caplin Steriles Limited is a fast-growing sterile product manufacturing company with 44 USFDA approvals and a portfolio of 40+ simple and complex Injectable and Ophthalmic products. Caplin Point Laboratories Limited is a fast-growing pharmaceutical company with state-of-the-art manufacturing facilities catering to a complete range of finished dosage forms.

Key Highlights

  • Caplin Steriles Limited received final approval from the USFDA for Linezolid Injection 600mg/300mL (2mg/mL) Single-dose Infusion Bags
  • Linezolid Injection is an anti-bacterial primarily used to treat serious bacterial infections
  • Caplin Steriles Limited is a fast-growing sterile product manufacturing company with 44 USFDA approvals
  • Caplin Point Laboratories Limited is a fast-growing pharmaceutical company with state-of-the-art manufacturing facilities
CAPPL
Pharmaceuticals
CAPLIN POINT LABORATORIES LTD.

Price Impact